+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Argatroban Market by Indication, End User, Product Type, Distribution Channel, Application - Global Forecast to 2030- Product Image
Argatroban Market by Indication, End User, Product Type, Distribution Channel, Application - Global Forecast to 2030- Product Image
Sale

Argatroban Market by Indication, End User, Product Type, Distribution Channel, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013907
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Argatroban market is experiencing steady growth, driven by evolving standards in anticoagulation therapy and increasing demand for precision control in clinical practice. Industry decision-makers are seeking clear direction on market trends, regulatory changes, and competitive positioning to optimize strategic planning and resource allocation.

Market Snapshot: Argatroban Market Size and Outlook

The Argatroban market expanded from USD 67.34 million in 2024 to USD 70.17 million in 2025. It is projected to continue growing at a CAGR of 4.10%, anticipated to reach USD 85.70 million by 2030. This growth is underpinned by the adoption of direct thrombin inhibitors in various care settings, growing preference for alternatives to heparin, and increased focus on safety and precision in anticoagulant therapy.

Scope & Segmentation

  • Indication: Heparin Induced Thrombocytopenia (with and without thrombosis), Percutaneous Coronary Intervention (for STEMI and Unstable Angina)
  • End User: Ambulatory Surgical Centers, Cardiac Centers, General Hospitals
  • Product Type: Brand, Generic
  • Distribution Channel: Drug Distributors, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
  • Application: Prophylactic Use (postoperative and preoperative), Therapeutic Use (acute care and surgical care)
  • Regions Covered: Americas (key US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, various Middle Eastern and African countries), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asian countries)
  • Key Companies: Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Mylan N.V., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Fresenius Kabi AG, Hospira Inc., Apotex Inc., Hikma Pharmaceuticals PLC

Key Takeaways for Senior Decision-Makers

  • Argatroban provides an alternative to heparin, particularly benefiting patients with heparin-induced complications, enhancing patient safety in sensitive cohorts.
  • Clinical advances and real-world evidence continue to refine therapeutic protocols, impacting both perioperative and acute cardiac care pathways.
  • Differentiation between brand and generic products shapes procurement strategies and impacts formulary management across hospital networks.
  • Strategic collaborations between biopharmaceutical companies, CROs, and technology vendors are catalyzing innovation in drug delivery and patient monitoring.
  • Regional disparities in market adoption reflect variations in regulatory frameworks, healthcare infrastructure, and access to advanced therapy options.
  • Digital health integration is enhancing dosage precision and outcome tracking, influencing purchasing decisions and long-term adherence strategies.

Tariff Impact: Navigating 2025 U.S. Policy Changes

The introduction of new U.S. tariff policies in 2025 has significantly altered the cost structure for argatroban by increasing import duties on key ingredients and finished pharmaceuticals. This regulatory adjustment challenges procurement budgets and incentivizes near-shoring of production and diversified sourcing. Proactive inventory and supplier management will be essential for maintaining supply chain resilience in response to these evolving trade conditions.

Methodology & Data Sources

This report utilizes a rigorous approach, combining secondary research from peer-reviewed journals and regulatory filings with primary interviews of clinicians, supply chain experts, and senior market participants. Proprietary datasets and recognized external data providers support quantitative modeling, while validation through triangulation ensures reliability and minimizes potential bias. Each phase adhered to strict quality control processes for data integrity.

Why This Report Matters

  • Delivers a multidimensional view of the argatroban market, enabling decision-makers to identify growth levers and mitigate emerging risks.
  • Equips stakeholders with actionable insights into segmentation dynamics, regional trends, and regulatory shifts that directly inform supply chain and portfolio strategies.
  • Supports evidence-based decision-making and strengthens business cases for new investments or market entry initiatives.

Conclusion

The Argatroban market is defined by technology-driven innovation, adaptive regulatory environments, and evolving care pathways. Senior leaders who leverage strategic segmentation and robust analytics will be best positioned to extract value and maintain competitive strength in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Argatroban Market, by Indication
8.1. Introduction
8.2. Heparin Induced Thrombocytopenia
8.2.1. HIT With Thrombosis
8.2.2. HIT Without Thrombosis
8.3. Percutaneous Coronary Intervention
8.3.1. PCI In STEMI
8.3.2. PCI In Unstable Angina
9. Argatroban Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Center
9.3. Hospital
9.3.1. Cardiac Center
9.3.2. General Hospital
10. Argatroban Market, by Product Type
10.1. Introduction
10.2. Brand
10.3. Generic
11. Argatroban Market, by Distribution Channel
11.1. Introduction
11.2. Drug Distributor
11.3. Hospital Pharmacy
11.4. Online Pharmacy
11.5. Retail Pharmacy
12. Argatroban Market, by Application
12.1. Introduction
12.2. Prophylactic Use
12.2.1. Postoperative Prophylaxis
12.2.2. Preoperative Prophylaxis
12.3. Therapeutic Use
12.3.1. Acute Care
12.3.2. Surgical Care
13. Americas Argatroban Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Argatroban Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Argatroban Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Sandoz International GmbH
16.3.4. Mylan N.V.
16.3.5. Dr. Reddy's Laboratories Ltd.
16.3.6. Sun Pharmaceutical Industries Ltd.
16.3.7. Fresenius Kabi AG
16.3.8. Hospira Inc.
16.3.9. Apotex Inc.
16.3.10. Hikma Pharmaceuticals PLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ARGATROBAN MARKET MULTI-CURRENCY
FIGURE 2. ARGATROBAN MARKET MULTI-LANGUAGE
FIGURE 3. ARGATROBAN MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ARGATROBAN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ARGATROBAN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARGATROBAN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARGATROBAN MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARGATROBAN MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARGATROBAN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARGATROBAN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ARGATROBAN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ARGATROBAN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ARGATROBAN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ARGATROBAN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ARGATROBAN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ARGATROBAN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ARGATROBAN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ARGATROBAN MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ARGATROBAN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARGATROBAN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARGATROBAN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARGATROBAN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARGATROBAN MARKET SIZE, BY HIT WITH THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARGATROBAN MARKET SIZE, BY HIT WITHOUT THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARGATROBAN MARKET SIZE, BY PCI IN STEMI, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARGATROBAN MARKET SIZE, BY PCI IN UNSTABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARGATROBAN MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARGATROBAN MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARGATROBAN MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARGATROBAN MARKET SIZE, BY GENERAL HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARGATROBAN MARKET SIZE, BY BRAND, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARGATROBAN MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARGATROBAN MARKET SIZE, BY DRUG DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARGATROBAN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARGATROBAN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARGATROBAN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARGATROBAN MARKET SIZE, BY POSTOPERATIVE PROPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARGATROBAN MARKET SIZE, BY PREOPERATIVE PROPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ARGATROBAN MARKET SIZE, BY ACUTE CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ARGATROBAN MARKET SIZE, BY SURGICAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ARGATROBAN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ARGATROBAN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. CANADA ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 62. CANADA ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 63. CANADA ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. CANADA ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 65. CANADA ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. CANADA ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 69. CANADA ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ARGATROBAN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. GERMANY ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 130. GERMANY ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 131. FRANCE ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. FRANCE ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 133. FRANCE ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 134. FRANCE ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. FRANCE ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 136. FRANCE ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. FRANCE ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. FRANCE ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. FRANCE ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 140. FRANCE ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 151. ITALY ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. ITALY ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 153. ITALY ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 154. ITALY ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. ITALY ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 156. ITALY ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ITALY ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. ITALY ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 160. ITALY ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 161. SPAIN ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 162. SPAIN ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 163. SPAIN ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SPAIN ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 166. SPAIN ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SPAIN ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 202. DENMARK ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 203. DENMARK ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 204. DENMARK ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. DENMARK ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 206. DENMARK ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. DENMARK ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. DENMARK ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 210. DENMARK ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 221. QATAR ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 222. QATAR ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 223. QATAR ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 224. QATAR ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. QATAR ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 226. QATAR ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. QATAR ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. QATAR ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. QATAR ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 230. QATAR ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 231. FINLAND ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 232. FINLAND ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 233. FINLAND ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 234. FINLAND ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. FINLAND ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 236. FINLAND ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. FINLAND ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. FINLAND ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. FINLAND ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 240. FINLAND ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 241. SWEDEN ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 261. EGYPT ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 262. EGYPT ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 263. EGYPT ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 264. EGYPT ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. EGYPT ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 266. EGYPT ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. EGYPT ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. EGYPT ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. EGYPT ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 270. EGYPT ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 271. TURKEY ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 272. TURKEY ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 273. TURKEY ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 274. TURKEY ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. TURKEY ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 276. TURKEY ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. TURKEY ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. TURKEY ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. TURKEY ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 280. TURKEY ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 291. NORWAY ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 292. NORWAY ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 293. NORWAY ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 294. NORWAY ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. NORWAY ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 296. NORWAY ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. NORWAY ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. NORWAY ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. NORWAY ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 300. NORWAY ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 301. POLAND ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 302. POLAND ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 303. POLAND ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 304. POLAND ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. POLAND ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 306. POLAND ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. POLAND ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. POLAND ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. POLAND ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 310. POLAND ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 311. SWITZERLAND ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 312. SWITZERLAND ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. SWITZERLAND ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 316. SWITZERLAND ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 321. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 322. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 323. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 324. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 326. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC ARGATROBAN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 332. CHINA ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 333. CHINA ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 334. CHINA ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 335. CHINA ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. CHINA ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 337. CHINA ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 338. CHINA ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. CHINA ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 340. CHINA ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 341. CHINA ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 342. INDIA ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 343. INDIA ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 344. INDIA ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 345. INDIA ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 346. INDIA ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 347. INDIA ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 348. INDIA ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 349. INDIA ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 350. INDIA ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 351. INDIA ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 352. JAPAN ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 353. JAPAN ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 354. JAPAN ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD MILLION)
TABLE 355. JAPAN ARGATROBAN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 356. JAPAN ARGATROBAN MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 357. JAPAN ARGATROBAN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 358. JAPAN ARGATROBAN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 359. JAPAN ARGATROBAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 360. JAPAN ARGATROBAN MARKET SIZE, BY PROPHYLACTIC USE, 2018-2030 (USD MILLION)
TABLE 361. JAPAN ARGATROBAN MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 362. AUSTRALIA ARGATROBAN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 363. AUSTRALIA ARGATROBAN MARKET SIZE, BY HEPARIN INDUCED THROMBOCYTOPENIA, 2018-2030 (USD MILLION)
TABLE 364. AUSTRALIA ARGATROBAN MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2030 (USD M

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Argatroban market report include:
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Mylan N.V.
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Fresenius Kabi AG
  • Hospira Inc.
  • Apotex Inc.
  • Hikma Pharmaceuticals PLC

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 70.17 Million
Forecasted Market Value ( USD ) by 2030 $ 85.7 Million
Compound Annual Growth Rate4.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Heparin-induced Thrombocytopenia - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Image

Heparin-induced Thrombocytopenia - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Antithrombotic Drugs Market by Drug Class, Indication, Route Of Administration, End User - Global Forecast to 2030 - Product Image

Antithrombotic Drugs Market by Drug Class, Indication, Route Of Administration, End User - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Antiplatelet Market by Drug Type, Drug Formulation, Indication, Mechanism of Action, Mode of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Antiplatelet Market by Drug Type, Drug Formulation, Indication, Mechanism of Action, Mode of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Rare Hemophilia Factors Market Size, Share & Trends Analysis Report by Factor Deficiency Type, Drug Class (Recombinant Therapies, Prophylactic Treatments), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region with Growth Forecasts, 2025-2030 - Product Image

Rare Hemophilia Factors Market Size, Share & Trends Analysis Report by Factor Deficiency Type, Drug Class (Recombinant Therapies, Prophylactic Treatments), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Immune Thrombocytopenia Market Insights, Epidemiology, and Market Forecast - 2034 - Product Image

Immune Thrombocytopenia Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • 207 Pages
  • Global
From

About the Argatroban Market

Argatroban is a hematological drug used to treat and prevent blood clots in patients with certain conditions. It is a direct thrombin inhibitor, meaning it works by blocking the action of thrombin, an enzyme involved in the clotting process. It is used to treat and prevent thrombosis in patients with heparin-induced thrombocytopenia (HIT), a condition in which the body produces antibodies against heparin, a commonly used anticoagulant. It is also used to treat and prevent thrombosis in patients with other conditions, such as atrial fibrillation and deep vein thrombosis. Argatroban is available in both intravenous and subcutaneous formulations. It is typically administered as an intravenous infusion over a period of several hours, or as a subcutaneous injection. The drug is available in a variety of strengths and formulations, and is typically prescribed by a doctor. The Argatroban market is highly competitive, with several companies offering the drug. Some of the major players in the market include Pfizer, Sanofi, Bristol-Myers Squibb, and Bayer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.